G 3719
Pill imprint G 3719 has been identified as Alprazolam 0.25 mg.
Alprazolam is used in the treatment of anxiety; depression; panic disorder; tinnitus; dysautonomia and belongs to the drug class benzodiazepines. There is positive evidence of human fetal risk during pregnancy.
Alprazolam 0.25 mg has a low potential for abuse. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 3.
See also related documents.
Alprazolam Images
- Imprint:
-
G 3719
- Strength:
- 0.25 mg
- Color:
- White
- Size:
- 9.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- cellulose powdered
corn starch
docusate sodium
lactose
magnesium stearate
silicon dioxide
sodium benzoate
- Drug Class:
- Benzodiazepines
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- 4 - Some potential for abuse
- Manufacturer:
- Greenstone Limited
- National Drug Code (NDC):
- 59762-3719
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54569-3755 | A S Medication Solutions LLC (repackager) |
| 63874-0251 | Altura Pharmaceuticals Inc (repackager) |
| 66336-0876 | Dispensing Solutions Inc. (repackager) |
| 67544-0414 | Prepak Systems Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Alprazolam resources
- Alprazolam
- Alprazolam (Wolters Kluwer)
- Alprazolam Extended-Release Tablets (Wolters Kluwer)
- Alprazolam Orally Disintegrating Tablets (Wolters Kluwer)
- Alprazolam Solution (Wolters Kluwer)
- alprazolam (Cerner Multum)
- Alti-Alprazolam (Micromedex) - Includes Dosage Information
- Gabazolamine-0.5 (Micromedex) - Includes Dosage Information
- alprazolam (Micromedex) - Includes Dosage Information
- Alprazolam (AHFS DI)
- Alprazolam (FDA)
- Alprazolam Extended Release (FDA)
- Alprazolam ODT (FDA)
- Alprazolam XR (FDA)
- Alprazolam (Wolters Kluwer)
Search Again
